Impact of Intraoperative PTCD Catheter Retention Versus Removal on Postoperative Short-term Outcomes After Pancreaticoduodenectomy in Obstructive Jaundice

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorXu'an Wang

About this trial

Pancreaticoduodenectomy (PD) is a complex surgical procedure commonly performed for tumors of the pancreatic head and periampullary region. Many patients present with obstructive jaundice and undergo preoperative percutaneous transhepatic cholangial drainage (PTCD) to relieve biliary obstruction. However, there is currently no consensus on whether the PTCD catheter should be removed or retained during surgery.

This multicenter, prospective randomized controlled trial aims to compare two intraoperative strategies: removal versus retention of the PTCD catheter during PD. Participants will be randomly assigned to either group. The study will evaluate whether these different approaches influence postoperative outcomes, particularly major complications such as bile leak and severe postoperative morbidity within 90 days after surgery.

In addition to complications, the study will assess recovery after surgery, including return of gastrointestinal function, length of hospital stay, and quality of recovery, as well as laboratory indicators of liver function and inflammation.

The results of this study are expected to provide evidence to guide surgical decision-making regarding PTCD management during PD and to improve patient outcomes.

Eligibility criteria

Qualifiers

Age 18 to 85 years

Patients with pancreatic head or periampullary tumors scheduled for pancreaticoduodenectomy

Presence of obstructive jaundice and completion of preoperative

percutaneous transhepatic cholangial drainage (PTCD)

Disqualifiers

Presence of distant metastasis or locally unresectable disease

Severe cardiac, renal, or pulmonary dysfunction that contraindicates surgery

Uncontrolled infection

Pregnancy or breastfeeding

Trial design

Treatments tested in this trial

  • PTCD Catheter Removal
  • PTCD Catheter Retention

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Xu'an Wang

Lead sponsor

Fudan University

Sponsor institution